YU67099A - Postupak za dobijanje tiazofurina i drugih c-nukleozida - Google Patents
Postupak za dobijanje tiazofurina i drugih c-nukleozidaInfo
- Publication number
- YU67099A YU67099A YU67099A YU67099A YU67099A YU 67099 A YU67099 A YU 67099A YU 67099 A YU67099 A YU 67099A YU 67099 A YU67099 A YU 67099A YU 67099 A YU67099 A YU 67099A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- nucleosides
- sugar
- class
- heterocycle
- preferred embodiments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/24—Heterocyclic radicals containing oxygen or sulfur as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
C-nukleozidi su sintetizovani po postupku u kome se šećer u jednom koraku pretvara u derivat, dajući heterocikl u položaju C1, a zatim se heterocikl aromatizuje u drugom koraku. U jednoj klasi poželjnih realizacija cijano-šećer se konvertuje u tiokarboksamid, a zatim kondenzuje, stvarajući azolski prsten. U drugoj klasi poželjnih realizacija cijano-šećer se kondenzuje sa amino kiselinom dajući azolski prsten. U trećoj klasi poželjnih realizacija halo-šećer se kondenzuje sa prethodno formiranim heterociklom, dajući azolski prsten.[C-nucleosides are synthesized by a method in which a sugar is derivatized in a single step to provide a heterocycle at the C1 position, and then the heterocycle is aromatized in another single step. In one class of preferred embodiments a cyano sugar is converted into thiocarboxamide, and subsequently condensed to form an azole ring. In a second class of preferred embodiments a cyano sugar is condensed with an amino acid to provide the azole ring. In a third class of preferred embodiments a halo sugar is condensed with a preformed heterocycle to provide the azole ring.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5119197P | 1997-06-30 | 1997-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU67099A true YU67099A (sh) | 2002-06-19 |
Family
ID=21969870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU67099A YU67099A (sh) | 1997-06-30 | 1998-06-25 | Postupak za dobijanje tiazofurina i drugih c-nukleozida |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6613896B1 (sh) |
| EP (1) | EP1000075A4 (sh) |
| JP (1) | JP2002501546A (sh) |
| KR (1) | KR100540853B1 (sh) |
| CN (1) | CN1261370A (sh) |
| AU (1) | AU735601B2 (sh) |
| BR (1) | BR9810364A (sh) |
| CA (1) | CA2290364A1 (sh) |
| HU (1) | HUP0002389A3 (sh) |
| IL (1) | IL132737A0 (sh) |
| NO (1) | NO996467L (sh) |
| NZ (1) | NZ500831A (sh) |
| PL (1) | PL191173B1 (sh) |
| RU (1) | RU2185385C2 (sh) |
| SI (1) | SI20161A (sh) |
| SK (1) | SK172399A3 (sh) |
| UA (1) | UA63956C2 (sh) |
| WO (1) | WO1999000399A1 (sh) |
| YU (1) | YU67099A (sh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050182252A1 (en) | 2004-02-13 | 2005-08-18 | Reddy K. R. | Novel 2'-C-methyl nucleoside derivatives |
| EP3105238A4 (en) | 2014-02-13 | 2017-11-08 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and their uses |
| EP3164136A4 (en) | 2014-07-02 | 2018-04-04 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and uses therof |
| US11970482B2 (en) | 2018-01-09 | 2024-04-30 | Ligand Pharmaceuticals Inc. | Acetal compounds and therapeutic uses thereof |
| JP2021519334A (ja) | 2018-03-26 | 2021-08-10 | クリア クリーク バイオ， インコーポレイテッド | ジヒドロオロト酸デヒドロゲナーゼを阻害するための組成物および方法 |
| TW202245800A (zh) | 2020-02-18 | 2022-12-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| JP7429799B2 (ja) | 2020-02-18 | 2024-02-08 | ギリアード サイエンシーズ， インコーポレイテッド | 抗ウイルス化合物 |
| TWI794742B (zh) | 2020-02-18 | 2023-03-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| WO2021189018A1 (en) | 2020-03-20 | 2021-09-23 | Clear Creek Bio, Inc. | Methods of treating viral infections using inhibitors of nucleotide synthesis pathways |
| AU2022256476A1 (en) | 2021-04-16 | 2023-10-12 | Gilead Sciences, Inc. | Methods of preparing carbanucleosides using amides |
| US12116380B2 (en) | 2021-08-18 | 2024-10-15 | Gilead Sciences, Inc. | Phospholipid compounds and methods of making and using the same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4451648A (en) * | 1981-08-19 | 1984-05-29 | The United States Of America As Represented By The Department Of Health And Human Services | Process for the production of 2-β-D-ribofuranosylthiazole-4-carboxamide |
| US4531001A (en) * | 1982-03-23 | 1985-07-23 | Brigham Young University | 2-β-D-ribofuranosylselenazole-4-carboxamide compounds |
| US4619996A (en) * | 1984-07-09 | 1986-10-28 | Warner-Lambert Company | Process for preparing 2-β-D-ribofuranosylselenazole-4-carboxamide |
| AU5298096A (en) * | 1995-02-17 | 1996-09-11 | Icn Pharmaceuticals, Inc. | Procedures for obtaining ribo-c-nucleosides |
| AU738170B2 (en) * | 1996-10-16 | 2001-09-13 | Icn Pharmaceuticals, Inc. | Monocyclic L-nucleosides, analogs and uses thereof |
-
1998
- 1998-06-25 NZ NZ500831A patent/NZ500831A/en unknown
- 1998-06-25 PL PL337716A patent/PL191173B1/pl not_active IP Right Cessation
- 1998-06-25 BR BR9810364-4A patent/BR9810364A/pt not_active IP Right Cessation
- 1998-06-25 EP EP98932904A patent/EP1000075A4/en not_active Withdrawn
- 1998-06-25 SK SK1723-99A patent/SK172399A3/sk unknown
- 1998-06-25 CN CN98806383A patent/CN1261370A/zh active Pending
- 1998-06-25 RU RU2000100307/04A patent/RU2185385C2/ru not_active IP Right Cessation
- 1998-06-25 JP JP50579799A patent/JP2002501546A/ja not_active Ceased
- 1998-06-25 UA UA99126884A patent/UA63956C2/uk unknown
- 1998-06-25 AU AU82688/98A patent/AU735601B2/en not_active Ceased
- 1998-06-25 IL IL13273798A patent/IL132737A0/xx unknown
- 1998-06-25 CA CA002290364A patent/CA2290364A1/en not_active Abandoned
- 1998-06-25 US US09/445,713 patent/US6613896B1/en not_active Expired - Fee Related
- 1998-06-25 WO PCT/US1998/013367 patent/WO1999000399A1/en not_active Application Discontinuation
- 1998-06-25 HU HU0002389A patent/HUP0002389A3/hu unknown
- 1998-06-25 YU YU67099A patent/YU67099A/sh unknown
- 1998-06-25 SI SI9820052A patent/SI20161A/sl not_active IP Right Cessation
- 1998-06-25 KR KR1019997012559A patent/KR100540853B1/ko not_active IP Right Cessation
-
1999
- 1999-12-23 NO NO996467A patent/NO996467L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL132737A0 (en) | 2001-03-19 |
| KR20010039514A (ko) | 2001-05-15 |
| RU2185385C2 (ru) | 2002-07-20 |
| EP1000075A4 (en) | 2001-09-05 |
| AU735601B2 (en) | 2001-07-12 |
| HUP0002389A3 (en) | 2002-04-29 |
| PL337716A1 (en) | 2000-08-28 |
| NO996467L (no) | 2000-02-23 |
| WO1999000399A9 (en) | 1999-04-15 |
| AU8268898A (en) | 1999-01-19 |
| PL191173B1 (pl) | 2006-03-31 |
| KR100540853B1 (ko) | 2006-01-10 |
| UA63956C2 (uk) | 2004-02-16 |
| EP1000075A1 (en) | 2000-05-17 |
| CN1261370A (zh) | 2000-07-26 |
| HUP0002389A2 (hu) | 2001-08-28 |
| SK172399A3 (en) | 2000-07-11 |
| BR9810364A (pt) | 2000-09-05 |
| NO996467D0 (no) | 1999-12-23 |
| CA2290364A1 (en) | 1999-01-07 |
| SI20161A (sl) | 2000-08-31 |
| NZ500831A (en) | 2001-06-29 |
| JP2002501546A (ja) | 2002-01-15 |
| WO1999000399A1 (en) | 1999-01-07 |
| US6613896B1 (en) | 2003-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002053517A3 (en) | Process for stereoselective synthesis of prostacyclin derivatives | |
| YU67099A (sh) | Postupak za dobijanje tiazofurina i drugih c-nukleozida | |
| CA2208777A1 (en) | Stent fabrication method | |
| EP0897985A3 (en) | Consensus phytases | |
| WO1999008649A3 (de) | Schaum-hautschutzcreme | |
| HK1047575A1 (en) | Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same. | |
| MXPA03003473A (es) | Metodos para producir compuestos de oxazolidinona. | |
| WO2001035990A3 (en) | Method for enhancing t cell reactivity toward tumour antigens | |
| EP0917873A4 (en) | EYE DROP | |
| PL1676782T3 (pl) | Sposób opakowywania przedmiotu(ów) za pomocą tulei termokurczliwych, i związana z nim osłona opakowania | |
| WO1999021830A8 (en) | Process for stereoselective synthesis of prostacyclin derivatives | |
| NZ503169A (en) | Synthesis of clasto-lactacystin beta-lactone whereupon the process relies upon a stereoselective addition of a formyl amide to an oxazoline | |
| MEP5808A (xx) | Ecitalopram bromhidrat i postupak za njegovo pripremanje | |
| WO2001040219A3 (de) | Verfahren zur herstellung von 5-(1-piperazinyl)-benzofuran-2-carboxamid durch übergansmetall-katalysierte aminierung | |
| CA2238278A1 (en) | Antigenic protein originating in malassezia | |
| MXPA03007992A (es) | Composicion farmaceutica de fragmentos f(ab)2 de anticuerpos y un proceso para su preparacion | |
| WO1999063053A3 (en) | Enzymatic modification of psyllium | |
| WO2003018565A8 (en) | Method for synthesizing oxazinones | |
| WO2001041734A3 (de) | Stabile galenische zubereitungen umfassend ein benzimidazol und verfahren zu ihrer herstellung | |
| EP1238652A4 (en) | COMBINATIONS FOR PEELINGS | |
| WO2000042987A3 (en) | Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections | |
| WO1996040041A3 (en) | Antibodies to fas antigen capable of inhibiting apoptosis | |
| WO1997002344A3 (fr) | Vaccin contre des agents infectieux, composition pour le traitement et la prevention des infections a hiv | |
| AU4459197A (en) | Diagnosis aid and process for detecting pregnancy in ruminants | |
| IE782565L (en) | Imidazole derivatives |